During the last session, IO Biotech Inc (NASDAQ:IOBT)’s traded shares were 0.46 million, with the beta value of the company hitting 0.36. At the end of the trading day, the stock’s price was $1.47, reflecting an intraday gain of 5.00% or $0.07. The 52-week high for the IOBT share is $1.73, that puts it down -17.69 from that peak though still a striking 55.1% gain since the share price plummeted to a 52-week low of $0.66. The company’s market capitalization is $96.84M, and the average intraday trading volume over the past 10 days was 0.21 million shares, and the average trade volume was 151.30K shares over the past three months.
IO Biotech Inc (IOBT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. IOBT has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
IO Biotech Inc (NASDAQ:IOBT) trade information
IO Biotech Inc (IOBT) registered a 5.00% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 5.00% in intraday trading to $1.47, hitting a weekly high. The stock’s 5-day price performance is -1.34%, and it has moved by -0.68% in 30 days. Based on these gigs, the overall price performance for the year is 59.78%. The short interest in IO Biotech Inc (NASDAQ:IOBT) is 0.14 million shares and it means that shorts have 0.66 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -27.25%. While earnings are projected to return 5.24% in 2025, the next five years will return 21.11% per annum.
IOBT Dividends
IO Biotech Inc is due to release its next quarterly earnings on 2025-May-14. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
IO Biotech Inc (NASDAQ:IOBT)’s Major holders
IO Biotech Inc insiders own 0.36% of total outstanding shares while institutional holders control 66.46%, with the float percentage being 66.70%. VIVO CAPITAL, LLC is the largest shareholder of the company, while 24.0 institutions own stock in it. As of 2024-06-30, the company held over 6.17 million shares (or 9.3706% of all shares), a total value of $7.22 million in shares.
The next largest institutional holding, with 4.43 million shares, is of NOVO HOLDINGS A/S’s that is approximately 6.7234% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $5.18 million.
